Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05126173 · ClinicalTrials.gov registry record
DERM US and EU Validation Study
A clinical trial of Squamous Cell Carcinoma and Basal Cell Carcinoma, sponsored by Skin Analytics Limited.
- Completed
- Registry status
- 1,111
- Enrollment target
- 16
- Study locations
NCT05126173: Completed study of Squamous Cell Carcinoma and Basal Cell Carcinoma, sponsored by Skin Analytics Limited.
NCT05126173 is a study of Squamous Cell Carcinoma and Basal Cell Carcinoma that has completed, run by Skin Analytics Limited. The registered enrollment target is 1,111 participants, above the 80-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (1289% higher). The trial reports 16 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05126173, a study of Squamous Cell Carcinoma and Basal Cell Carcinoma, has completed, sponsored by Skin Analytics Limited.
- COMPLETED
- Registry status
- 1,111 participants
- Enrollment target
- 16
- Study locations
Study Summary
This study aims establish the effectiveness of Image Analysing Algorithm (DERM) to identify melanoma, Squamous Cell Carcinoma (SCC) and Basal Cell Carcinoma (BCC) when used to analyse dermoscopic images of skin lesions within the US and European population.
Primary Outcome
Sensitivity of DERM to detect Melanoma, SCC and BCC combined
Conditions Studied
Interventions
- DEVICE Deep Ensemble for the Recognition of Malignancy (DERM)
Study Locations (16)
Other
- Universitaria Di Bologna - Bologna
- Dermatology University of Florence - Florence
- Università degli Studi di Modena e Reggio Emilia - Modena
- University of Campania - Naples
- Università del Piemonte Orientale - Novara
- UOSD Dermatology Oncology - Roma
Florida
- Vista Health Research, LLC - Miami
- Dorisca Research Consulting, LLC - Miami
Massachusetts
- ALLCUTIS Research, LLC - Beverly
- Allcutis Research - Methuen
California
- Stanford university - Redwood City
Illinois
- Northwestern University - Chicago
New York
- Universal Dermatology, PLLC - Fairport
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Texas
- Alpesh D. Desai, DO, PLLC, a Houston company institution - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,111 participants |
| Start Date | 2022-03-15 |
| Est. Completion | 2022-09-15 |
What the finished NCT05126173 record still lists
NCT05126173 is an observational study that tracks outcomes without assigning an intervention. Its 1,111 participants enrollment target places it among the larger protocols in the corpus, above the 80-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (1289% higher).
The record links to 3 conditions, with Squamous Cell Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Deep Ensemble for the Recognition of Malignancy (DERM) is the first listed.
NCT05126173 lists 16 locations in 9 states (Other, Florida, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT05126173 about?
NCT05126173 is a clinical study titled "DERM US and EU Validation Study". This study aims establish the effectiveness of Image Analysing Algorithm (DERM) to identify melanoma, Squamous Cell Carcinoma (SCC) and Basal Cell Carcinoma (BCC) when used to analyse dermoscopic images of skin lesions within the US and European population.
What is the current status of trial NCT05126173?
This trial is currently completed. The enrollment target is 1,111 participants. The study started on 2022-03-15. Estimated completion is 2022-09-15.
What conditions does trial NCT05126173 study?
This clinical trial studies the following conditions: Squamous Cell Carcinoma, Basal Cell Carcinoma, Malignant Skin Melanoma T0.
What interventions are being tested in trial NCT05126173?
The interventions under investigation include: Deep Ensemble for the Recognition of Malignancy (DERM) (DEVICE).
Who is sponsoring clinical trial NCT05126173?
This trial is sponsored by Skin Analytics Limited, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05126173 being conducted?
This trial has 16 study locations across California, Florida, Illinois, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Squamous Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05126173's enrollment target sits among peer trials
1,111 1st of 47 higher than 47 of 47 other Squamous Cell Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Squamous Cell Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
RECRUITING · Phase 2
-
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
RECRUITING · NA
-
Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin
RECRUITING · Phase 2
-
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
RECRUITING · Phase 1
-
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
RECRUITING · NA
-
Toripalimab With Chemotherapy for Sinus Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT07164131 · 1,120 participants · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI